Next Article in Journal
Can the Metabolome Be Used to Assess Dietary Pattern Consumption? A Systematic Review of Evidence from Observational Studies
Previous Article in Journal
Twenty-Four-Hour Urinary Sodium and Potassium Excretion in Children and Young People: A Systematic Review and Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Yacon Concentrate NZFOS+, Its Phytochemical Contents, Health-Related Properties and Potential Applications †

1
AUT Food Network, Auckland University of Technology, Auckland 1010, New Zealand
2
Healthcare and Social Practice, Unitec Institute of Technology, Auckland 1025, New Zealand
3
School of Science, Auckland University of Technology, Auckland 1010, New Zealand
*
Author to whom correspondence should be addressed.
Presented at the Nutrition Society of New Zealand Annual Conference, Online, 2–3 December 2021.
Med. Sci. Forum 2022, 9(1), 41; https://doi.org/10.3390/msf2022009041
Published: 24 May 2022

Abstract

:
Yacon (Smallanthus sonchifolius), a sustainable foodstuff, is perceived as a functional food because it contains biologically active components, e.g., fructooligosaccharides (FOS), inulin, and phenolic compounds that may provide physiological benefits beyond basic nutrition to reduce the risk of chronic diseases. There is a growing public interest in why and how to use yacon. Yacon, originally from South America, has been grown in New Zealand (NZ) since the 1980’s. NZ-produced yacon concentrate NZFOS+ contains the purest natural prebiotic FOS. Our study aimed to examine the phytochemical contents of NZFOS+ and its health-related properties. The glycemic index of yacon concentrate was measured by ISO 26642:2010(E) (n = 10). Total phenolic and flavonoid contents were measured by the spectrometric method. The chlorogenic acid content and phenolic profiling were measured using the liquid chromatography coupled with mass spectrometry (LC-MS). The antioxidant activity of the yacon concentrate and Manuka honey were compared using the cupric reducing antioxidant capacity (CUPRAC), ferric ion reducing antioxidant power (FRAP), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) assays. The results indicated that compared to Manuka honey, yacon concentrate has a lower glycemic index (40 vs. 52); a higher content of total phenolic (5430 mg vs. 744 mg GAE/100 g), total flavonoid (329 mg vs. 22 mg QE/100 g), and chlorogenic acid (11.88 μg vs. 0.08 μg CA/g); and across all assays observed, a significantly higher antioxidant capacity (CUPRAC assay, 892 mg vs. 52.6 mg TE/100 g; FRAP assay, 633 mg vs. 47 mg TE/100 g; DPPH assay, 383 mg vs. 22 mg TE/100 g, respectively). Yacon concentrate has proven potential health benefits and applications associated with the maintenance of health and wellbeing and prevention of chronic diseases. Further investigations are needed for human studies and new applications and use of yacon concentrate. Yacon concentrate (NZFOS+) has potential markets in the development of new food products and new diet therapy applications, e.g., in the form of syrup, and functional prebiotic drinks.

Author Contributions

Methodology, R.K.; data collection, R.P., E.Q. and K.C.; data analysis, R.K., R.P., E.Q., K.C. and M.R.Y.; draft preparation and review, M.R.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Yacon New Zealand Ltd.

Institutional Review Board Statement

The glycemic index test has been approved by the Human Research Ethics Committee of the University of Sydney: 2017/801.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the glycemic index test.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The glycemic index of yacon concentrate was tested by Sydney University’s Glycemic Index Research Service.

Conflicts of Interest

There is no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yan, M.R.; Permal, R.; Quach, E.; Chessum, K.; Kam, R. Yacon Concentrate NZFOS+, Its Phytochemical Contents, Health-Related Properties and Potential Applications. Med. Sci. Forum 2022, 9, 41. https://doi.org/10.3390/msf2022009041

AMA Style

Yan MR, Permal R, Quach E, Chessum K, Kam R. Yacon Concentrate NZFOS+, Its Phytochemical Contents, Health-Related Properties and Potential Applications. Medical Sciences Forum. 2022; 9(1):41. https://doi.org/10.3390/msf2022009041

Chicago/Turabian Style

Yan, Mary R., Rahul Permal, Edward Quach, Keegan Chessum, and Rothman Kam. 2022. "Yacon Concentrate NZFOS+, Its Phytochemical Contents, Health-Related Properties and Potential Applications" Medical Sciences Forum 9, no. 1: 41. https://doi.org/10.3390/msf2022009041

APA Style

Yan, M. R., Permal, R., Quach, E., Chessum, K., & Kam, R. (2022). Yacon Concentrate NZFOS+, Its Phytochemical Contents, Health-Related Properties and Potential Applications. Medical Sciences Forum, 9(1), 41. https://doi.org/10.3390/msf2022009041

Article Metrics

Back to TopTop